Atlas of AIDS pp 273-293 | Cite as

HIV Infection in Women

  • Mary Ann Chiasson
  • Thomas C. WrightJr.

Keywords

Human Immunodeficiency Virus Human Immunodeficiency Virus Infection Cervical Intraepithelial Neoplasia Pelvic Inflammatory Disease Invasive Cervical Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gwinn M, Pappaioanou M, George JR, et al.: Prevalence of HIV infection in childbearing women in the United States: Surveillance using newborn blood samples. JAMA 1991, 265:1704–1708.PubMedCrossRefGoogle Scholar
  2. 2.
    Report on the global HIV/AIDS epidemic. UNAIDS/WHO. June 1998.Google Scholar
  3. 3.
    Minkoff H, Willoughby A: Pediatric HIV disease, zidovudine in pregnancy, and unblinding heelstick surveys: reframing the debate on prenatal HIV testing. JAMA 1995, 274:1165–1168.PubMedCrossRefGoogle Scholar
  4. 4.
    Dabis F, Msellati P, Dunn D, et al.: Estimating the rate of mother-to-child transmission of HIV: Report of a workshop on methological issues. Ghent (Belgium). AIDS 1993, 7:1139–1148.PubMedCrossRefGoogle Scholar
  5. 5.
    Connor EM, Sperling RS, Gelber R, et al.: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994, 331:1173–1180.PubMedCrossRefGoogle Scholar
  6. 6.
    Centers for Disease Control and Prevention: Recommendations for the use of zidovudine to reduce perinatal transmission of a human immunodeficiency virus. MMWR 1994, 43(RR-11).Google Scholar
  7. 7.
    De Cock KM, Fowler MG, Mercier E, et al.: Prevention of mother-to-child HIV transmission in resource-poor countries: Translating research into policy and practice. JAMA 2000, 283:1175–1182.PubMedCrossRefGoogle Scholar
  8. 8.
    Dickover RE, Garratty EM, Herman SA, et al.: Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission: Effect of maternal zidovudine treatment on viral load. JAMA 1996, 275:599–605.PubMedCrossRefGoogle Scholar
  9. 9.
    Holmberg SD, Horsburgh CR Jr, Ward JW, et al.: Biologic factors in the sexual transmission of human immunodeficiency virus. J Infect Dis 1989, 160:116–125.PubMedCrossRefGoogle Scholar
  10. 10.
    Royce RA, Sena A, Cates W Jr., et al.: Sexual transmission of HIV. N Engl J Med 1997, 336:1072–1078.PubMedCrossRefGoogle Scholar
  11. 11.
    Quinn TC, Wawer MJ, Sewankambo N, et al.: Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000,342:921–929.PubMedCrossRefGoogle Scholar
  12. 12.
    Division of STD/HIV Prevention: Sexually Transmitted Disease Surveillance 1998. Atlanta: Centers for Disease Control and Prevention, 1999.Google Scholar
  13. 13.
    Coppleson M, Reid B: Preclinical Carcinoma of the Cervix Uteri. Oxford: Pergamon Press. 1967.Google Scholar
  14. 14.
    Linhartova A: Extent of columnar epithelium on the ectocervix between the ages of 1 and 13 years. Obstet Gynecol 1978, 52:451–456.PubMedGoogle Scholar
  15. 15.
    McCormack WM, Rosner B, McComb DE, et al.: Infection with Chlamydia trachomatis in female college students. Am J Epidemiol 1985, 121:107–115.PubMedGoogle Scholar
  16. 16.
    Brinton LA: Oral contraceptives and cervical neoplasia. Contraception 1991, 43:581–595.PubMedCrossRefGoogle Scholar
  17. 17.
    Schiffman MH, Bauer HM, Hoover RN, et al.: Epidemiological evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993, 85:958–964.PubMedCrossRefGoogle Scholar
  18. 18.
    zur Hausen H: Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991, 184:9–13.PubMedCrossRefGoogle Scholar
  19. 19.
    Penn I: Cancers of the anogenital region in renal transplant recipients. Cancer 1986, 58:611–616.PubMedCrossRefGoogle Scholar
  20. 20.
    Rellihan MA, Dooley DP, Burke TW, et al.: Rapidly progressing cervical cancer in a patient with human immunodeficiency virus infection. Gynecol Oncol 1990, 36:435–438.PubMedCrossRefGoogle Scholar
  21. 21.
    Schwartz LB, Carcangiu ML, Bradham L, et al.: Rapidly progressive squamous carcinoma of the cervix coexisting with human immunodeficiency virus infection: Clinical opinion. Gynecol Oncol 1991, 41:255–258.PubMedCrossRefGoogle Scholar
  22. 22.
    Giorda G, Vaccher E, Volpe R, et al.: Case report: An unusual presentation of vulvar carcinoma in an HIV patient. Gynecol Oncol 1992, 44:191–194.PubMedCrossRefGoogle Scholar
  23. 23.
    Wright TC, Koulos JP, Liu P, et al.: Case report: Invasive vulvar carcinoma in two women infected with human immunodeficiency virus. Gynecol Oncol 1996,60:500–503.PubMedCrossRefGoogle Scholar
  24. 24.
    Massad SL, Ahuja J, Bitterman P: Case Report. Verrucous carcinoma of the vulva in a patient infected with human immunodeficiency virus. Gynecol Oncol 1999, 73:315–318.PubMedCrossRefGoogle Scholar
  25. 25.
    Provencher D, Valme B, Averette HE, et al.: HIV status and positive Papanicolaou screening: Identification of a high-risk population. Gynecol Oncol 1988, 31:184–188.PubMedCrossRefGoogle Scholar
  26. 26.
    Carpenter CCJ, Mayer KH, Stein MD, et al: Human immunodeficiency virus infection in North American women: Experience with 200 cases and a review of the literature. Medicine 1991, 70:307–325.PubMedCrossRefGoogle Scholar
  27. 27.
    Vermund SH, Kelley KF, Klein RS, et al.: High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol 1991, 165:392–400.PubMedGoogle Scholar
  28. 28.
    Schafer A, Friedmann W, Mielke M, et al.: The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol 1991, 164:593–599.PubMedGoogle Scholar
  29. 29.
    Kreiss JK, Kiviat NB, Plummer FA, et al.: Human immunodeficiency virus, human papillomavirus, and cervical intraepithelial neoplasia in Nairobi prostitutes. Sex Trans Dis 1992, 19:54–59.CrossRefGoogle Scholar
  30. 30.
    Wright TC, Ellerbrock TV, Chiasson MA, et al.: Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: Prevalence, risk factors and validity of Papanicolaou smears. Obstet Gynecol 1994, 84:591–597.PubMedGoogle Scholar
  31. 31.
    Laga M, Icenogle JP, Marsella R, et al.: Genital papillomavirus infection and cervical dysplasia — opportunistic complications of HIV infection. Int J Cancer 1992,50:45–48.PubMedCrossRefGoogle Scholar
  32. 32.
    Maggwa BN, Hunter DJ, Mbugua S, et al.: The relationship between HIV infection and cervical intraepithelial neoplasia among women attending two family planning clinics in Nairobi, Kenya. AIDS 1993, 7:733–738.PubMedCrossRefGoogle Scholar
  33. 33.
    Chiasson MA, Kelley KF, Williams R, et al.: Invasive cervical cancer in HIV+ women in New York City. Presented at the 3rd Conference on Retroviruses and Opportunistic Infections; 1996; Washington, DC.Google Scholar
  34. 34.
    New York City Department of Health: AIDS Case Surveillance Report, November 1999.Google Scholar
  35. 35.
    Bradbeer C: Is infection with HIV a risk factor for cervical intraepithelial neoplasia? Lancet 1987, 11:1277–1278.CrossRefGoogle Scholar
  36. 36.
    Spurrett B, Jones DS, Stewart G: Cervical dysplasia and HIV infection. Lancet 1988. i:237–238.CrossRefGoogle Scholar
  37. 37.
    Crocchiolo P, Lizioli A, Goisis F, et al.: Cervical dysplasia and HIV infection. Lancet 1988. i:238–239.Google Scholar
  38. 38.
    Byrne M, Taylor-Robinson D, Harris JRW: Cervical dysplasia and HIV infection. Lancet 1988. i:239.Google Scholar
  39. 39.
    Ellerbrock TV, Chiasson MA, Bush TJ, et al.: Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000, 283:1031–1037.PubMedCrossRefGoogle Scholar
  40. 40.
    Marte C, Kelly P, Cohen M, et al.: Papanicolaou smear abnormalities in ambulatory care sites for women infected with the human immunodeficiency virus. Am J Obstet Gynecol 1992, 166:1232–1237.PubMedGoogle Scholar
  41. 41.
    ter Meulen J, Eberhardt HC, Luande J, et al.: Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, East Africa. Int J Cancer 1992, 51:515–521.PubMedCrossRefGoogle Scholar
  42. 42.
    Sun X-W, Ellerbrock TV, Lungo O, et al.: Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstet Gynecol 1995, 85: 680–686.PubMedCrossRefGoogle Scholar
  43. 43.
    Wright TC Jr, Sun X-W: Anogenital papillomavirus infection and neoplasia in immunodeficient women. Obstet Gynecol Clin North Am 1996, 23:861–893.PubMedCrossRefGoogle Scholar
  44. 44.
    Spinillo A, Tenti P, Zappatore R, et al.: Prevalence, diagnosis and treatment of lower genital neoplasia in women with human immunodeficiency virus infection. Eur J Obstet Gynecol 1992, 43:235–241.CrossRefGoogle Scholar
  45. 45.
    Maiman M, Fruchter RG, Serur E, et al.: Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Obstet Gynecol 1993, 82:170–174.PubMedGoogle Scholar
  46. 46.
    McGuinness K. LaGuardia K: Cryotherapy in the management of cervical dysplasia in HIV infected women. Presented at the IX International Conference on AIDS, Berlin, 1993:409.Google Scholar
  47. 47.
    Wright TC Jr, Koulos J, Schnoll F, et al.: Cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus: outcome after loop electrosurgical excision. Gynecol Oncol 1994, 55:253–258.PubMedCrossRefGoogle Scholar
  48. 48.
    Maiman M, Watts DH, Andersen J, et al.: Vaginal 5-fluorouracil for high-grade cervical dysplasia in human immnuodeficiency virus infection: a randomized trial. Obstet Gynecol 1999, 94:954–961.PubMedCrossRefGoogle Scholar
  49. 49.
    Byrne MA, Taylor-Robinson D, Munday PE, et al.: The common occurrence of human papillomavirus infection and intraepithelial neoplasia in women infected by HIV. AIDS 1989, 3:379–382.PubMedCrossRefGoogle Scholar
  50. 50.
    Smith JR, Kitchen VS, Botcherby M, et al.: Is HIV infection associated with an increase in the prevalence of cervical neoplasia? Br J Obstet Gynecol 1993, 100:149–153.CrossRefGoogle Scholar
  51. 51.
    Chiasson MA, Ellerbrock TV, Bush TJ, et al.: Increased prevalence of vulvovaginal condyloma and vulvar intraepithelial neoplasia in women infected with the human immunodeficiency virus. Obstet Gynecol 1997, 89:690–694.PubMedCrossRefGoogle Scholar
  52. 52.
    Korn AP, Autry M, DeRemer PA, et al.: Sensitivity of the Papanicolaou smear in human immunodeficiency virus-infected women. Obstet and Gynecol 1994, 83:401–104.Google Scholar
  53. 53.
    Irwin KL, Moorman AC, O’Sullivan MJ, et al.: Influence of human immunodeficiency virus infection on pelvic inflammatory disease. Obstet Gynecol 2000, 95:525–534.PubMedCrossRefGoogle Scholar
  54. 54.
    Safrin S, Dattel BJ, Hauer L, et al.: Seroprevalence and epidemiologic correlates of human immunodeficiency virus infection in women with acute pelvic inflammatory disease. Obstet Gynecol 1990, 75:666–670.PubMedGoogle Scholar
  55. 55.
    Hoegsberg B, Abulafia O, Sedlis A. et al.: Sexually transmitted diseases and human immunodeficiency virus among women with pelvic inflammatory disease. Am J Obstet Gynecol 1990, 163:1135–1139.PubMedGoogle Scholar
  56. 56.
    Sperling RS, Friedman F Jr, Joyner M, et al.: Seroprevalence of human immunodeficiency virus in women admitted to the hospital with pelvic inflammatory disease. Reprod Med 1991, 36:122–124.Google Scholar
  57. 57.
    Korn AP, Landers DV, Green JR, et al.: Pelvic inflammatory disease in human immunodeficiency virus-infected women. Obstet Gynecol 1993 82:765–768.PubMedGoogle Scholar
  58. 58.
    Carpenter CCJ, Cooper DA, Fischl MA, et al.: Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society — USA Panel. JAMA 2000, 283:381–390.PubMedCrossRefGoogle Scholar
  59. 59.
    Farzadegan H, Hoover DR, Astemborski J, et al.: Sex differences in HIV-1 viral load and progression to AIDS. Lancet 1998, 352:1510–1514.PubMedCrossRefGoogle Scholar
  60. 60.
    Moroni M: Sex differences in HIV-1 viral load and progression to AIDS. ICONA Study Group. Italian cohort of HIV-1 positive individuals [letter]. Lancet 1999, 353:589–590.PubMedCrossRefGoogle Scholar
  61. 61.
    Moore RD, Cheever L, Kenruly JC, et al.: Lack of sex difference in CD4 to HIV-1 RNA viral ratio. Lancet 1999, 353:463–464.PubMedCrossRefGoogle Scholar
  62. 62.
    Junghans C, Ledergerber B, Chan P, et al.: Sex differences in HIV-1 viral load and progression to AIDS. Swiss HIV Cohort Study [letter]. Lancet 1999,353:589.PubMedCrossRefGoogle Scholar
  63. 63.
    Anastos K, Kalish L, Hessol N, et al.: The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1 infected women: results of the women’s interagency HIV study. AIDS 1999,13:1717–1725.PubMedCrossRefGoogle Scholar
  64. 64.
    Chiasson MA, Berenson L, Li W, et al. Declining HIV/AIDS mortality in New York City. J AIDS 1999, 21:59–64.Google Scholar

Selected Bibliography

  1. De Cock KM, Fowler MG, Mercier E, et al.: Prevention of mother-to-child HIV transmission in resource-poor countries: Translating research into policy and practice. JAMA 2000, 283:1175–1182.PubMedCrossRefGoogle Scholar
  2. Ellerbrock TV, Chiasson MA, Bush TJ, et al: Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000, 283:1031–1037.PubMedCrossRefGoogle Scholar
  3. Irwin KL, Moorman AC, O’Sullivan MJ, et al.: Influence of human immunodeficiency virus infection on pelvic inflammatory disease. Obstet Gynecol 2000, 95:525–534.PubMedCrossRefGoogle Scholar
  4. Quinn TC, Wawer MJ, Sewankambo N, et al.: Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000, 342:921–929.PubMedCrossRefGoogle Scholar
  5. Royce RA, Sena A, Cates W Jr., Cohen MS: Sexual transmission of HIV. N Engl J Med 1997, 336:1072–1078.PubMedCrossRefGoogle Scholar
  6. Wortley PM, Fleming PL: AIDS in women in the United States. Recent trends. JAMA 1997, 278:911–916.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Mary Ann Chiasson
  • Thomas C. WrightJr.

There are no affiliations available

Personalised recommendations